2m 2m 2m 2m 2m 2m 2m
QUINCE THERAP (QNCX)
NASDAQ
$25.20+$0.23 (+0.92%)
Price as of Aug 03, 2026 7:34 PM EDT- $22.9MMarket Cap
- -92.34%1-Year Change
- BiotechnologyIndustry
QUINCE THERAP (QNCX)
$25.20+$0.23 (+0.92%)
QNCX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $24.96 | ||
Change | +$1.58 (+6.73%) | ||
Open | $23.50 | ||
High | $26.61 | ||
Low | $23.50 | ||
Previous Close | $23.39 | ||
Volume | 54,412 | ||
30-Day Average Volume | 37,472 | ||
1-Week Change | 39.86% | ||
1-Month Change | 44.89% | ||
1-Year Change | -92.34% | ||
3-Year Change | -89.85% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 977,963 | ||
Total Assets | $26.6M | ||
Market Cap | $22.9M | ||
Enterprise Value | $4.7M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | $35.9M | ||
Free Cash Flow | -$7.6M | ||
EBIT | $30.6M | ||
EBITDA | $30.6M | ||
Net Working Capital | $16.8M | ||
EPS | $576.00 | ||
Enterprise Value/EBITDA | 0 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | 0 | ||
PEG | 0 | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 06/30/2026 | ||
Earnings & Revenue